Siren Fund Exits $52.87 Million Position in Ascendis Pharma

On May 14, 2026, Siren disclosed the sale of its entire stake in Ascendis Pharma A/S (NASDAQ:ASND), valued at approximately $52.87 million based on Q1 average pricing. The transaction involved 235,862 shares and marked a significant reduction from the fund's previous position.

By Jonathan Ponciano, The Motley Fool Thu, May 14, 2026 at 10:05 PM GMT+3 4 min read · Yahoo Finance · May 14, 2026, 19:05 UTC

Siren Fund Exits $52.87 Million Position in Ascendis Pharma

Tickers: $ASND

Topics: investment funds SEC filings stock sales

Read the full article at Yahoo Finance

More World news

Nvidia Shares Decline Following Resignation of CEO Jensen Huang Seeking Alpha · November 12, 2026, 16:07 UTC
Broadcom and Micron Identified as Top Alternatives to Nvidia Amid Leadership Uncertainty Motley Fool · November 12, 2026, 16:03 UTC
Thomson Reuters Executives to Present at TD Securities Technology Conference PR Newswire · November 12, 2026, 16:00 UTC
BHP to Restructure Australian Iron Ore Operations Amid Rising Costs Seeking Alpha · November 12, 2026, 15:59 UTC
Capri Investment Group and GRIT Chicago Unveil $10 Billion Bronzeville Lakefront Development Plan PR Newswire · November 12, 2026, 16:00 UTC
Whoop Launches 'Whoop Humans' Social Network to Enhance Health Data Sharing TechCrunch · November 12, 2026, 16:00 UTC
SchoolWise Partners Advises on Sale of Wyalusing Valley and Wysox Children's Centers PR Newswire · November 12, 2026, 15:57 UTC
Jensen Huang Resigns as Nvidia CEO Amid Personal Scandal and Leadership Crisis CNBC · November 12, 2026, 15:45 UTC
Keurig Dr Pepper Launches $2 Billion Equity Offering to Reduce Debt Ahead of Corporate Split Seeking Alpha · November 12, 2026, 15:51 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC